Penn International Head & Neck Cancer TORS & Reconstruction Symposium
Head and Neck Cancer involves multiple classes of malignancy arising from a diverse number of sites with a wide range of effects on an individual’s ability to function in the world. The diagnosis and treatment of these cancers is constantly evolving over time. With the Penn International Head & Neck Cancer, TORS, & Reconstruction Symposium, we aim to provide an update regarding the management of cancers of the Oral Cavity, Oropharynx, Larynx, Thyroid, Neck, and Skin. Focused attention will be paid to TranOral Robotic Surgery (TORS) in the management of oropharyngeal cancer due to the increasing incidence of this disease as well as the inventive approaches and innovation that is practiced at the University of Pennsylvania. The conference is geared to educate general otolaryngologists who care for patients with head and neck cancer as well as head and neck surgical oncologists who would like to advance their knowledge further.
Upon completion of this course, participants should be able to:
- Identify the most up-to-date oncologic indications and contraindications for the use of the robot surgical system in oropharyngeal cancer
- Evaluate the indications and contraindications for primary surgery and primary chemoradiation in the management of bulky T3 laryngeal tumors
- Assess the newest approaches to the resection and reconstruction of complex oral cavity cancers
- Describe the management of thyroid cancer using the most recent American Thyroid Association guidelines
- Discuss the role of the multidisciplinary team in the management of locally advanced cutaneous malignancies
This program is designed for General Otolaryngologists, Head and Neck Surgeons, Oral Surgeons, Endocrine Surgeons, Dermatologists, Radiation Oncologists, Medical Oncologists, and other related health care professionals such as Speech Language Pathologists, nurses, nurse practitioners and physician assistants.